Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer.
Rich P, Mitchell RB, Schaefer E, Walker PR, Dubay JW, Boyd J, Oubre D, Page R, Khalil M, Sinha S, Boniol S, Halawani H, Santos ES, Brenner W, Orsini JM, Pauli E, Goldberg J, Veatch A, Haut M, Ghabach B, Bidyasar S, Quejada M, Khan W, Huang K, Traylor L, Akerley W. Rich P, et al. Among authors: traylor l. J Immunother Cancer. 2021 Oct;9(10):e002989. doi: 10.1136/jitc-2021-002989. J Immunother Cancer. 2021. PMID: 34706885 Free PMC article.
When basal insulin is not enough: response to M Davidson.
Umpierrez GE, Skolnik N, Dex T, Traylor L, Chao J, Shaefer C. Umpierrez GE, et al. Among authors: traylor l. Diabetes Obes Metab. 2020 Apr;22(4):711-712. doi: 10.1111/dom.13916. Epub 2019 Dec 5. Diabetes Obes Metab. 2020. PMID: 31724245 No abstract available.
Interprofessional transformation of clinical education: The first six years of the Veterans Affairs Centers of Excellence in Primary Care Education.
Harada ND, Traylor L, Rugen KW, Bowen JL, Smith CS, Felker B, Ludke D, Tonnu-Mihara I, Ruberg JL, Adler J, Uhl K, Gardner AL, Gilman SC. Harada ND, et al. Among authors: traylor l. J Interprof Care. 2023 Sep 1;37(sup1):S86-S94. doi: 10.1080/13561820.2018.1433642. Epub 2018 Feb 20. J Interprof Care. 2023. PMID: 29461131
The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL.
Hanefeld M, Traylor L, Gao L, Landgraf W. Hanefeld M, et al. Among authors: traylor l. Cardiovasc Diabetol. 2017 May 19;16(1):66. doi: 10.1186/s12933-017-0548-0. Cardiovasc Diabetol. 2017. PMID: 28526014 Free PMC article.
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.
Owens DR, Bolli GB, Charbonnel B, Haak T, Landgraf W, Porcellati F, Traylor L, Kautzky-Willer A. Owens DR, et al. Among authors: traylor l. Diabetes Obes Metab. 2017 Nov;19(11):1546-1554. doi: 10.1111/dom.12966. Epub 2017 Jul 27. Diabetes Obes Metab. 2017. PMID: 28449412
Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials.
Polonsky W, Traylor L, Gao L, Wei W, Ameer B, Stuhr A, Vlajnic A. Polonsky W, et al. Among authors: traylor l. J Diabetes Complications. 2017 Mar;31(3):562-568. doi: 10.1016/j.jdiacomp.2016.11.018. Epub 2016 Dec 8. J Diabetes Complications. 2017. PMID: 28040350
31 results